# Phase I Study of Intrathecal Topotecan

> **NCT00001333** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 30 (—)

## Conditions studied

- Leukemia
- Lymphoma
- Meningeal Neoplasms

## Interventions

- **DRUG:** topotecan

## Key facts

- **NCT ID:** NCT00001333
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-02
- **Primary completion:** —
- **Final completion:** 2000-12
- **Target enrollment:** 30 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001333, "Phase I Study of Intrathecal Topotecan". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00001333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*